Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats.
Pre-diabetic subjects with high insulin secretory capacity have double risk of cardiovascular disease compared with subjects who do not develop insulin-resistance. It is well established that the ability of the myocardium to increase its glycolytic ATP production plays a crucial role in determining cell survival under conditions of ischemia. Up to now, whether the pre-diabetic state reduces the tolerance of the heart to ischemia by affecting its ability to increase its energy production through glycolysis remains unknown. The aim of the present study was to assess whether insulin resistance affects the ability of the myocardium to increase glycolysis under ischemic conditions. Male Wistar rats were fed for 8 weeks a fructose-enriched (33%) diet to induce a pre-diabetic state. Hearts were isolated and subjected to ex-vivo low-flow (2%) ischemia for 30 min. The fructose diet increased sarcolemmal GLUT4 localisation in myocardial cells under basal conditions compared with controls. This effect was not accompanied by increased glucose utilisation. Ischemia induced the translocation of GLUT4 to the plasma membrane in controls but did not significantly modify the distribution of these transporters in pre-diabetic hearts. Glycolytic flux under ischemic conditions was significantly lower in fructose-fed rat hearts compared with controls. The reduction of glycolytic flux during ischemia in fructose-fed rat hearts was not due to metabolic inhibition downstream hexokinase II since no cardiac accumulation of glucose-6-phosphate was detected. In conclusion, our results suggest that the pre-diabetic state reduces the tolerance of the myocardium to ischemia by decreasing glycolytic flux adaptation.
Morel
Sandrine
S
Laboratoire Nutrition, Vieillissement et Maladies Cardiovasculaires, IFRT Ingénierie pour le Vivant, Université Joseph Fourier, Grenoble, France.
Berthonneche
Corinne
C
Tanguy
Stéphane
S
Toufektsian
Marie-Claire
MC
Perret
Pascale
P
Ghezzi
Catherine
C
de Leiris
Joël
J
Boucher
François
F
D000222:Adaptation, Physiological; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000378:metabolism*; D005632:Fructose / Q000008:administration & dosage; D005947:Glucose / Q000378:metabolism*; D051275:Glucose Transporter Type 4; D006003:Glycogen / Q000032:analysis; D006019:Glycolysis; D006600:Hexosephosphates / Q000032:analysis; D066298:In Vitro Techniques; D007333:Insulin Resistance; D019344:Lactic Acid / Q000032:analysis; D008297:Male; D009004:Monosaccharide Transport Proteins / Q000032:analysis / Q000378:metabolism*; D009124:Muscle Proteins / Q000032:analysis / Q000378:metabolism*; D017202:Myocardial Ischemia / Q000150:complications / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D032383:Myocytes, Cardiac / Q000737:chemistry / Q000378:metabolism; D011236:Prediabetic State / Q000139:chemically induced / Q000378:metabolism*; D021381:Protein Transport; D051381:Rats; D017208:Rats, Wistar; D012508:Sarcolemma / Q000737:chemistry / Q000378:metabolism
D051275:Glucose Transporter Type 4; D006600:Hexosephosphates; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; C495694:Slc2a4 protein, rat; D005632:Fructose; D019344:Lactic Acid; D006003:Glycogen; D005947:Glucose